- No comment
- Tags: drug, FDA, Med Man, product liability, Recall, sildenafil, tainted, UP2
Up2 by Med Man Distribution: Recall
Med Man Distribution is voluntarily recalling its supplement, UP2. The dietary supplement, advertised for its lebido enhancing abilities in men and women, has been found to contain amounts of Sildenafil, which is an FDA-approved prescription drug for erectile dysfunction. Med Man Distribution does not have approval to distribute Sildenafil, thus warranting a full recall of all UP2.
The affected Up2 Dietary supplement lots include:
- 240 ten count units upc is 85606300322
- 480 four count packages upc 856063006315
- 960 singlepack units upc 856063006308.
Up2 was distributed in the USA to Regal Labs and to their nationwide retailers. To date, Med Man has not received any reports of adverse events related to this recall.
Health professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program: